C-Kit and stem cell factor regulate PANC-1 cell differentiation into insulin-and glucagon-producing cells

Laboratory Investigation

Volumn 90, Issue 9, 2010, Pages 1373-1384

  Wu, Yuexiu ^a   Li, Jinming ^a   Saleem, Saira ^a   Yee, Siu Pok ^a,c   Hardikar, Anandwardhan A ^b   Wang, Rennian ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b OBrien Institute   (Australia)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; C PEPTIDE; GLUCAGON; INSULIN; OCTAMER TRANSCRIPTION FACTOR 4; SMALL INTERFERING RNA; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PDX 1; HORMONE; MESSENGER RNA; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCAGON RELEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; INSULIN RELEASE; NICK END LABELING; PANCREAS DUCT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CHEMISTRY; CYTOLOGY; GENETICS; METABOLISM; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PHYSIOLOGY;

CELL DIFFERENTIATION; CELL PROLIFERATION; GLUCAGON; GLUCAGON-SECRETING CELLS; HORMONES; HUMANS; INSULIN; ISLETS OF LANGERHANS; PANCREATIC DUCTS; RNA, MESSENGER; STEM CELL FACTOR; TRANSCRIPTION FACTORS;

EID: 77956248555     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.106     Document Type: Article

References (41)

1. Sachs DH, Bonner-Weir S. New islets from old. Nat Med 2000;6:250-251.
2. Zwillich T. Diabetes research. Islet transplants not yet ready for prime time. Science 2000;289:531-533.
3. Maria-Engler SS, Mares-Guia M, Correa ML, et al. Microencapsulation and tissue engineering as an alternative treatment of diabetes. Braz J Med Biol Res 2001;34:691-697.
4. Bretzel RG, Eckhard M, Brendel MD. Pancreatic islet and stem cell transplantation: new strategies in cell therapy of diabetes mellitus. Panminerva Med 2004;46:25-42.
5. Lechner A, Habener JF. Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am J Physiol Endocrinol Metab 2003;284:E259-E266.
6. Linnekin D. Early signaling pathways activated by c-Kit in hematopoietic cells. Int J Biochem Cell Biol 1999;31:1053-1074.
7. Oberg-Welsh C, Welsh M. Effects of certain growth factors on in vitro maturation of rat fetal islet-like structures. Pancreas 1996;12:334-339.
8. Rachdi L, El Ghazi L, Bernex F, et al. Expression of the receptor tyrosine kinase KIT in mature beta-cells and in the pancreas in development. Diabetes 2001;50:2021-2028.
9. Li J, Quirt J, Do HQ, et al. Expression of c-Kit receptor tyrosine kinase and effect on beta-cell development in the human fetal pancreas. Am J Physiol Endocrinol Metab 2007;293:E475-E483.
10. Yashpal NK, Li J, Wang R. Characterization of c-Kit and nestin expression during islet cell development in the prenatal and postnatal rat pancreas. Dev Dyn 2004;229:813-825.
11. Li J, Goodyer CG, Fellows F, et al. Stem cell factor/c-Kit interactions regulate human islet-epithelial cluster proliferation and differentiation. Int J Biochem Cell Biol 2006;38:961-972.
12. Wang R, Li J, Yashpal N. Phenotypic analysis of c-Kit expression in epithelial monolayers derived from postnatal rat pancreatic islets. J Endocrinol 2004;182:113-122.
13. Krishnamurthy M, Ayazi F, Li J, et al. c-Kit in early onset of diabetes: a morphological and functional analysis of pancreatic beta-cells in c-KitW~v mutant mice. Endocrinology 2007;148:5520-5530.
14. Lieber M, Mazzetta J, Nelson-Rees W, et al. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer 1975;15:741-747.
15. Githens S. The pancreatic duct cell: proliferative capabilities, specific characteristics, metaplasia, isolation, and culture. J Pediatr Gastroenterol Nutr 1988;7:486-506.
16. Hardikar AA, Marcus-Samuels B, Geras-Raaka E, etal. Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates. Proc Natl Acad Sci USA 2003;100:7117-7122.
17. Graham FL, Smiley J, Russell WC, et al. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-72.
18. Mashima H, Ohnishi H, Wakabayashi K, et al. Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J Clin Invest 1996;97:1647-1654.
19. Mashima H, Shibata H, Mine T, et al. Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology 1996;137:3969-3976.
20. Zhou J, Wang X, Pineyro MA, et al. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon-and insulin-producing cells. Diabetes 1999;48:2358-2366.
21. Wang RN, Rosenberg L. Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. J Endocrinol 1999;163:181-190.
22. Lumelsky N, Blondel O, Laeng P, et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-1394.
23. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998;95:379-391.
24. Wei C, Geras-Raaka E, Marcus-Samuels B, et al. Trypsin and thrombin accelerate aggregation of human endocrine pancreas precursor cells. J Cell Physiol 2006;206:322-328.
25. Misiti S, Anastasi E, Sciacchitano S, et al. 3,5,3′-Triiodo-L- thyronine enhances the differentiation of a human pancreatic duct cell line (hPANC-1) towards a beta-cell-like phenotype. J Cell Physiol 2005;204:286-296.
26. Habener JF, Kemp DM, Thomas MK. Minireview: transcriptional regulation in pancreatic development. Endocrinology 2005;146:1025-1034.
27. Lyttle BM, Li J, Krishnamurthy M, et al. Transcription factor expression in the developing human fetal endocrine pancreas. Diabetologia 2008;51:1169-1180.
28. Sander M, Neubuser A, Kalamaras J, et al. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev 1997;11:1662-1673.
29. St Onge L, Sosa-Pineda B, Chowdhury K, et al. Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 1997;387:406-409.
30. Broudy VC, Morgan DA, Lin N, et al. Stem cell factor influences the proliferation and erythroid differentiation of the MB-02 human erythroleukemia cell line by binding to a high-affinity c-kit receptor. Blood 1993;82:436-444.
31. Konig A, Corbacioglu S, Ballmaier M, et al. Downregulation of c-kit expression in human endothelial cells by inflammatory stimuli. Blood 1997;90:148-155.
32. Ashman LK. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 1999;31:1037-1051.
33. Yasuda A, Sawai H, Takahashi H, et al. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells. Mol Cancer 2006;5:46.
34. Huang EJ, Nocka KH, Buck J, et al. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell 1992;3:349-362.
35. Dolci S, Williams DE, Ernst MK, et al. Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature 1991;352:809-811.
36. Godin I, Deed R, Cooke J, et al. Effects of the steel gene product on mouse primordial germ cells in culture. Nature 1991;352:807-809.
37. Metcalf D, Nicola NA. Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: effects of combination with colony-stimulating factors. Proc Natl Acad Sci USA 1991;88: 6239-6243.
38. Munugalavadla V, Kapur R. Role of c-Kit and erythropoietin receptor in erythropoiesis. Crit Rev Oncol Hematol 2005;54:63-75.
39. Kambe N, Miyachi Y. A possible mechanism of mast cell proliferation in mastocytosis. J Dermatol 2002;29:1-9.
40. Ren X, Hogaboam C, Carpenter A, et al. Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy. J Clin Invest 2003;112:1407-1418.
41. Hassan HT, Zander A. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis. Acta Haematol 1996;95:257-262.